Your search for supplemental oxygen returned 9 results

A recently published case report describes the case of a 36-year-old male chronic heart failure patient who, “spontaneously expectorated an intact cast of the right bronchial tree,” following an extreme bout of coughing.

The study, which was fully remote and contactless, aimed to evaluate whether early treatment with fluvoxamine reduced the likelihood of clinical deterioration and disease severity in patients with mild COVID-19 illness.

The patient, who had a history significant for cerebral palsy, seizures, and chronic constipation, had presented complaining of 3 days of fever, nausea, vomiting, and anorexia.

The patient, a 74-year-old female, presented to the ER after experiencing a low grade fever, cough, and shortness of breath for 2 days.

The first US clinical trial to assess the efficacy and safety of an investigational broad-spectrum antiviral agent, remdesivir (Gilead Sciences, Inc.), for the treatment of coronavirus disease 2019.

Recommendations on the management of coronavirus disease 2019 (COVID-19) were recently released by the National Institutes of Health (NIH) to help guide clinicians caring for patients with COVID-19.

Treatment with inhaled nitric oxide has been shown to have both pulmonary and antiviral benefits.

Treatment with remdesivir was associated with a shorter time to recovery in patients hospitalized with coronavirus disease 2019 (COVID-19), according to peer-reviewed data published in the New England Journal of Medicine.

A recently published systematic review investigated the benefits and risks of melatonin supplementation for pediatric patients with sleep disturbances.